Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil, and polysorbate 80

IEEE Transactions on Nanobioscience

Volumn 12, Issue 2, 2013, Pages 72-78

  How, Chee W ^a   Rasedee, Abdullah ^a   Abbasalipourkabir, Roghayeh ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BALB c 3T3 cell; cytotoxicity; drug carriers; particle growth kinetics; physicochemical characterization

Indexed keywords

COLLOIDAL DRUG CARRIERS; DRUG CARRIER; NANOSTRUCTURED LIPID CARRIER (NLC); NANOSTRUCTURED LIPID CARRIERS; PARTICLE GROWTH KINETICS; PHYSICO-CHEMICAL CHARACTERIZATION; POLYDISPERSITY INDICES; SERUM-SUPPLEMENTED MEDIUM;

BODY FLUIDS; CELLS; CYTOLOGY; EMULSIONS; GROWTH KINETICS; HYDROGENATION; LIPIDS; OLIVE OIL; PALM OIL; SURFACE ACTIVE AGENTS; ZETA POTENTIAL;

CYTOTOXICITY;

BOVINAE;

DRUG CARRIER; LIPID; NANOMATERIAL; POLYSORBATE; SURFACTANT;

3T3 CELL LINE; ANIMAL; CELL SURVIVAL; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECTS; HYDROGENATION; MOUSE; PARTICLE SIZE; SURFACE PROPERTY; TOXICITY; ARTICLE; CELL STRAIN 3T3; DRUG EFFECT;

ANIMALS; BALB 3T3 CELLS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; CRYSTALLIZATION; DRUG CARRIERS; HYDROGENATION; LIPIDS; MICE; NANOSTRUCTURES; PARTICLE SIZE; POLYSORBATES; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 84878690257     PISSN: 15361241     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNB.2012.2232937     Document Type: Article

References (43)

1. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, "Therapeutic nanoparticles for drug delivery in cancer, " Clin. Cancer Res., vol. 14, p. 1310, Nov. 2011.
2. C. L. Dennis, A. J. Jackson, J. A. Borchers, P. J. Hoopes, R. Strawbridge, A. R. Foreman, J. V. Lierop, C. Grüttner, and R. Ivkov, "Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia, " Nanotechnology, vol. 20, no. 39, p. 395193, Sep. 2009.
3. C. Y. Zhuang, N. Li, M. Wang, X. N. Zhang, W. S. Pan, J. J. Peng, Y. S. Pan, and X. Tang, "Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability, " Int. J. Pharmaceutics, vol. 394, no. 1, pp. 179-185, May 13, 2010.
4. A. Luchini, C. Fredolini, B. H. Espina, F. Meani, A. Reeder, S. Rucker, E. F. Petricoin, and L. A. Liotta, "Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery, " J. Mater. Chem., vol. 10, pp. 5071-5077, Apr. 2009.
5. G. M. Barratt, "Therapeutic applications of colloidal drug carriers, " Pharmaceutical Sci. Technol. Today, vol. 3, no. 5, pp. 163-171, May 2000. (Pubitemid 30261519)
6. R. H. Müller, K. Madar, and S. Gohla, "Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art, " Eur. J. Pharmaceutics Biopharmaceutics, vol. 50, pp. 161-177, Jul. 2000. (Pubitemid 30326695)
7. L. D. Hu, X. Tang, and F. D. Cui, "Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs, " J. Pharmacy Pharmacology, vol. 56, pp. 1527-1535, Feb. 2010.
8. R. Wang, L. Li, B. Wang, T. Zhang, and L. Sun, "FK506-loaded solid lipid nanoparticles: Preparation, characterization and in vitro transdermal drug delivery, " African J. Pharmacy Pharmacology, vol.
9. pp. 904-913, Mar. 2012.
10. J. Y. Fang, C. L. Fang, C. H. Liu, and Y. H. Su, "Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), " Eur. J. Pharmaceutics Biopharmaceutics, vol. 70, pp. 633-640, Jun. 2008.
11. E. Souto and R. H. Müller, "SLN and NLC for topical delivery of ketoconazole, " J. Microencapsulation, vol. 22, no. 5, pp. 501-510, May 2005. (Pubitemid 43123888)
12. R. H. Müller, M. Radtke, and S. A. Wissing, "Nanostructured lipid matrices for improved microencapsulation of drugs, " Int. J. Pharmaceutics, vol. 242, pp. 121-128, Aug. 2002.
13. R. H. Müller, M. Radtke, and S. A. Wissing, "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, " Adv. DrugDel. Rev., vol. 54, pp. 495 S131-495 S155, Nov. 2002, Suppl 1.
14. G. Oberdörster, E. Oberdörster, and J. Oberdörster, "Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles, " Environ. Health Perspectives, vol. 113, pp. 823-839, Jul. 2005. (Pubitemid 40984181)
15. C. W. How, A. Rasedee, and R. Abbasalipourkabir, "Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with Polysorbate 20 and Polysorbate 80, " African J. Biotechnol., vol. 10, pp. 1684-1689, Feb. 2011.
16. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Mäder, "Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy, " J. Controlled Release, vol. 95, pp. 217-227, Mar. 2004. (Pubitemid 38230037)
17. M. A. Schubert and C. C. Müller-Goymann, "Characterization of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier, " Eur. J. Pharmaceutics Biopharmaceutics, vol.
18. pp. 77-86, Sep. 2005.
19. NIEHS (National Institute of Environmental Health Sciences), "Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity, " Research Triangle Park, NC, USA, NIH Publ. 01-4499, 2001.
20. B. Hong Chung, B. Hennig, B. Cho, and B. E. Darnell, "Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma, " Atherosclerosis, vol. 141, pp. 321-332, May 1998. (Pubitemid 28539640)
21. H. Babich and F. Visioli, "In vitro cytotoxicity of human cells in culture of some phenolics from olive oil, " Il Farmaco, vol. 58, pp. 403-407, May 2003. (Pubitemid 36506948)
22. A. Balakrishnan, B. D. Rege, G. L. Amidon, and J. E. Polli, " Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity, " J. Pharmaceutical Sci., vol. 93, pp. 2064-2075, Aug. 2004. (Pubitemid 39045487)
23. C. Olbrich and R. H. Müller, "Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures, " Int. J. Pharmaceutics, vol. 180, pp. 31-39, Mar. 1999. (Pubitemid 29131440)
24. R. Ernst and J. Arditti, "Biological effects of surfactants, VI. Effects of non-ionics and amphoterics on HeLa cells, " Toxicology, vol. 15, pp. 233-242, 1980. (Pubitemid 10118344)
25. R. Abbasalipourkabir, A. Salehzadeh, and A. Rasedee, "Antitumor activity of tamoxifen loaded solid lipid nanoparticles on induced mammary tumor gland in Sprague-Dawley rats, " African J. Biotechnol., vol.
26. pp. 7337-7345, Oct. 2010.
27. R. Lander, W. Manger, M. Scouloudis, A. Ku, O. Davis, and A. Lee, "Gaulin homogenization: A mechanistic study, " Biotechnol. Progress, vol. 16, pp. 80-85, Jan.-Feb. 2000. (Pubitemid 30097655)
28. Y. Yuan, Y. Gao, J. Zhao, and L. Mao, "Characterization and stability evaluation of-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions, " Food Res. Int. J., vol. 41, no. 1, pp. 61-68, Sep. 2007.
29. P. Ekambaram, A. A. H. Sathali, and K. Priyanka, "Solid lipid nanoparticles: A review, " Sci. Rev. Chem. Commun., vol. 2, pp. 80-102, Feb. 2012.
30. F. Q. Hu, S. P. Jiang, Y. Z. Du, H. Yuan, Y. Q. Ye, and S. Zeng, "Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system, " Colloids Surfaces B, Biointerfaces, vol. 45, pp. 167-173, Nov. 2005. (Pubitemid 41415646)
31. M. S. Bakshi, A. Kaura, G. Kaur, K. Torigoe, and K. Esumi, "Effect of sodium dodecylsulfate and dodecyltrimethyl ammonium bromide on the morphologies of gold nanoparticles in the presence of poly(amidoamine) dendrimers, " J. Nanosci. Nanotechnol., vol. 6, pp. 644-650, Mar. 2006. (Pubitemid 44576144)
32. B. Bergenståhl, "Physicochemical aspects of an emulsifier functionality, " in Food Emulsifiers and Their Applications Second Edition. New York: Springer Science Business Media, 2008, pp. 173-194.
33. S. Bastian, W. Busch, D. Kühnel, A. Springer, T. Meißner, R. Holke, S. Scholz, M. Iwe, W. Pompe, M. Gelinsky, A. Potthoff, V. Richter, C. Ikonomidou, and K. Schirmer, "Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro, " Environ. Health Prospectives, vol. 117, pp. 530-536, Apr. 2009.
34. T. Meißner, A. Potthoff, and V. Richter, "Suspension characterization as important key for toxicological investigation, " J. Physics, Conf. Series, vol. 170, no. 1, p. 012012, 2009.
35. A. Petri-Fink and H. Hofmann, "Superparamagnetic iron oxide nanoparticles (SPIONs): From synthesis to in vivo studies-A summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties, " IEEE Trans. NanoBiosci., vol. 6, pp. 289-297, Dec. 2007. (Pubitemid 350210542)
36. D. K. Chou, R. Krishnamurthy, T. W. Randolph, J. F. Carpenter, and M. C. Manning, "Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation, " J. Pharmaceutical Sci., vol. 94, pp. 1368-1381, Jun. 2005. (Pubitemid 40904199)
37. C. H. Liu, B. Q. Li, and C. C. Mi, "Fast transient thermal analysis of gold nanoparticles in tissue-like medium, " IEEE Trans. NanoBiosci., vol. 8, pp. 271-280, Sep. 2009.
38. C. Freitas and R. H. Müller, "Correlation between long-termstability of Solid Lipid Nanoparticles (SLN) and crystallinity of the lipid phase, " Eur. J. Pharmaceutics Biopharmaceutics, vol. 47, pp. 125-132, Mar. 1999. (Pubitemid 29185115)
39. S. L. McGill, C. L. Cuylear, N. L. Adolphi, M. Osinski, and H. D. C. Smyth, "Magnetically responsive nanoparticles for drug delivery applications using low magnetic field strengths, " IEEE Trans. NanoBiosci., vol. 8, pp. 33-42, Mar. 2009.
40. F. Wan, J. You, Y. Sun, X. G. Zhang, F. D. Cui, Y. Z. Du, H. Yuan, and F. Q. Du, "Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): Preparation and evaluation in vitro, " Int. J. Pharmaceutics, vol. 585-359, pp. 104-110, Jul. 2008.
41. E. B. Souto and R. H. Müller, "Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization, " J. Microencapsulation, vol. 23, pp. 377-388, Jun. 2006. (Pubitemid 44132547)
42. E. Zimmermann, E. B. Souto, and R. H. Müller, "Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H-NMR, " Die Pharmazie, vol. 60, pp. 508-513, Jul. 2005. (Pubitemid 41025565)
43. R. H. Müller, D. Rühl, S. Runge, K. Schulze-Forster, andW. Mehnert, "Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant, " Pharmaceutical Res., vol. 14, pp. 458-462, Apr. 1997. (Pubitemid 27205004)